These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2976362)

  • 1. Carboxyfluorescein distribution in ocular tissues of normal and diabetic rats.
    Grimes PA
    Curr Eye Res; 1988 Oct; 7(10):981-8. PubMed ID: 2976362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyfluorescein transfer across the blood-retinal barrier evaluated by quantitative fluorescence microscopy: comparison with fluorescein.
    Grimes PA
    Exp Eye Res; 1988 May; 46(5):769-83. PubMed ID: 3384022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein distribution in retinas of normal and diabetic rats.
    Grimes PA
    Exp Eye Res; 1985 Aug; 41(2):227-38. PubMed ID: 4065247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microscopic quantification of fluorescein distribution in retinas of normal and diabetic rats].
    Proença D; Proença RD; Cunha-Vaz JG
    J Fr Ophtalmol; 1990; 13(10):489-91. PubMed ID: 2081838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyfluorescein. A probe of the blood-ocular barriers with lower membrane permeability than fluorescein.
    Grimes PA; Stone RA; Laties AM; Li W
    Arch Ophthalmol; 1982 Apr; 100(4):635-9. PubMed ID: 7073583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.
    Alrashdi SF; Deliyanti D; Wilkinson-Berka JL
    Exp Eye Res; 2018 Nov; 176():1-9. PubMed ID: 29944850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
    Bahgat M; Anis HH; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
    Int Ophthalmol; 1991 Sep; 15(5):335-41. PubMed ID: 1835966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes.
    Kirber WM; Nichols CW; Grimes PA; Winegrad AI; Laties AM
    Arch Ophthalmol; 1980 Apr; 98(4):725-8. PubMed ID: 6445186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcein fluorophotometry in streptozocin-induced diabetic rats.
    Golshani MR; Khoobehi B; Peyman GA; Aras C
    Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.
    Enea NA; Hollis TM; Kern JA; Gardner TW
    Arch Ophthalmol; 1989 Feb; 107(2):270-4. PubMed ID: 2521787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of streptozotocin-induced diabetes on the concentration of immunoreactive somatostatin in the retina and peripheral blood of the rat: effect of insulin treatment.
    Ariznavarreta C; Fernandez-Durango R
    J Endocrinol; 1987 Sep; 114(3):363-7. PubMed ID: 2889787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of diabetes on transport through the blood-retinal and blood-brain barriers in rats.
    Taarnhöj J; Alm A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):291-3. PubMed ID: 1831178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.